T1	Participants 63 116	childhood/adolescent pervasive developmental disorder
T2	Participants 383 416	children and adolescents with PDD
T3	Participants 418 550	Eleven patients with a diagnosis of either autism, Asperger's syndrome, or PDD not otherwise specified (PDD-NOS) and aged 6-14 years
